Core Viewpoint - China Smart Health (00348.HK) expects to report a profit attributable to shareholders ranging from approximately HKD 100,000 to HKD 2,000,000 for the six months ending June 30, 2025, a significant turnaround from a loss of approximately HKD 29,000,000 in the same period of 2024 [1] Financial Performance - The expected profit turnaround is primarily due to the reversal of impairment losses on receivables, with an estimated recovery of approximately HKD 3,000,000 in the 2025 period compared to an impairment loss of approximately HKD 6,000,000 in the 2024 period [1] - General and administrative expenses decreased from approximately HKD 18,000,000 in the 2024 period to approximately HKD 8,000,000 in the 2025 period, attributed to effective cost-saving measures implemented by the company [1] - The company recorded an unrealized fair value gain on financial assets of approximately HKD 12,000,000 in the 2025 period, contrasting with an unrealized fair value loss of approximately HKD 5,000,000 in the 2024 period [1]
中国智能健康(00348.HK)预计中期由亏转盈